FDA Inspection 1130595 — Aamir Z. Jamal, MD

Aamir Z. Jamal, MD — FEI 3006019672

The FDA completed an inspection of Aamir Z. Jamal, MD on August 25, 2020 in San Dimas, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 25, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Dimas, CA (United States)

Additional Details

Clinical Investigator (CI)